These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3015472)

  • 1. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study.
    Park CH; Suh JH; Yoo HS; Lee JT; Kim DI
    Clin Nucl Med; 1986 Jul; 11(7):514-7. PubMed ID: 3015472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatocellular carcinoma (HCC) with radiolabeled Lipiodol: a preliminary report.
    Park CH; Suh JH; Yoo HS; Lee JT; Kim DI; Kim BS
    Nucl Med Commun; 1987 Dec; 8(12):1075-87. PubMed ID: 2835716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma.
    Madsen MT; Park CH; Thakur ML
    J Nucl Med; 1988 Jun; 29(6):1038-44. PubMed ID: 2836572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.
    Ohishi H; Uchida H; Yoshimura H; Ohue S; Ueda J; Katsuragi M; Matsuo N; Hosogi Y
    Radiology; 1985 Jan; 154(1):25-9. PubMed ID: 2981114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
    Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
    Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings.
    Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Madsen MT
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S54-8. PubMed ID: 2538267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
    Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
    Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
    [No Abstract]   [Full Text] [Related]  

  • 8. 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer.
    Yu J; Häfeli UO; Sands M; Dong Y
    Appl Radiat Isot; 2003 May; 58(5):567-73. PubMed ID: 12735973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
    Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
    Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraarterial HCC therapy with I-131-Lipiodol.
    Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
    Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol].
    Raoul JL; Duvauferrier R; Bourguet P; Bretagne JF; Coornaert S; Darnault P; Deugnier Y; Herry JY; Gastard J
    J Radiol; 1986 Nov; 67(11):797-801. PubMed ID: 3027321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Semiautomated Module for Preparation of
    Mukherjee A; Subramanian S; Ambade R; Avhad B; Dash A; Korde A
    Cancer Biother Radiopharm; 2017 Feb; 32(1):33-37. PubMed ID: 28128645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
    Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
    Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of hepatic artery injection of iodized oil and 131I-labeled iodized oil before the therapeutic decision in hepatocellular carcinoma.
    Raoul JL; Duvauferrier R; Bretagne JF; Bourguet P; Heresbach D; Siproudhis L; Gosselin M
    Scand J Gastroenterol; 1993 Mar; 28(3):217-23. PubMed ID: 7680489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
    Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
    Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma detected by iodized oil.
    Yumoto Y; Jinno K; Tokuyama K; Araki Y; Ishimitsu T; Maeda H; Konno T; Iwamoto S; Ohnishi K; Okuda K
    Radiology; 1985 Jan; 154(1):19-24. PubMed ID: 2981112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol.
    Yoo HS; Park CH; Lee JT; Kim KW; Yoon CS; Suh JH; Park CY; Kim BS; Choi HJ; Lee KS
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S128-33. PubMed ID: 8137473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
    Tan SB; Machin D; Cheung YB; Chung YF; Tai BC; Machin D
    J Clin Oncol; 2002 Mar; 20(6):1709. PubMed ID: 11896125
    [No Abstract]   [Full Text] [Related]  

  • 20. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
    Shinto AS; Karuppusamy KK; Kurup RER; Pandiyan A; Jayaraj AV
    Nucl Med Commun; 2021 Jan; 42(1):43-50. PubMed ID: 32956248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.